Items Tagged ‘Julie Allickson’
January 26, 2023
Aspiring to deliver new cures for complex conditions
Mayo Clinic is building toward a future when biologics can cure cancer, kidney disease and diabetes. Mayo marks 2022 as a year of significant strides in accelerating science to make and deliver regenerative biotherapeutics. The goal is to offer new options, based on rigorous research in cell and gene therapies, for disorders with few available […]
Tags: 3D bioprinting, biologics, biomanufacturing, CAR-T cell therapy, Center for Regenerative Biotherapeutics, Julie Allickson, purified exosome product, stromal vascular fraction cells, tissue engineering
September 8, 2022
A new name for Center for Regenerative Medicine
Mayo Clinic’s Center for Regenerative Medicine has been renamed the Center for Regenerative Biotherapeutics. The name change reflects Mayo’s new strategic focus: manufacturing next-generation biotherapeutics for patients. The new name emphasizes how regenerative medicine at Mayo Clinic has evolved to advance groundbreaking discoveries toward curative products — biotherapeutics — for patients. The Center for Regenerative […]
Tags: Cell therapy, Center for Regenerative Biotherapeutics, gene therapy, Julie Allickson
August 30, 2022
Biomanufacturing 101: Understanding a new era of therapeutics
Advancing discoveries such as cellular therapies from clinical trials to commercial therapy is a cornerstone of Mayo Clinic’s strategic emphasis on biomanufacturing. The long-term vision is to provide new cures for patients with unmet needs. “Biomanufacturing is a type of manufacturing that utilizes sources from the human body — cells, blood, enzymes, tissues, genes or […]
Tags: biologics, biomanufacturing, CAR-T cell therapy, Center for Regenerative Medicine, Julie Allickson, regnerative biotherapeutics
July 28, 2022
Bringing regenerative technology of the future to patients today
“The sky’s the limit,” “possibility” and “potential cure for disease” are aspirational ways Mayo Clinic physicians and scientists described regenerative medicine in a recent virtual presentation at the World Stem Cell Summit 2022. Mayo’s panel discussion showcased how it is advancing regenerative medicine through industry collaborations that accelerate scientific discoveries to early stage clinical trials. […]
Tags: 3D printing, Abba Zubair, biomanufacturing, Center for Regenerative Medicine, David Lott, Julie Allickson, Saranya Wyles, tissue engineering, World Stem Cell Summit
April 21, 2022
Global spotlight on Mayo Clinic’s regenerative biotherapeutics
Mayo Clinic will showcase its work in discovering, manufacturing and delivering next-generation biotherapeutics with an international audience interested in advancing lifesaving cell and gene therapies. Mayo Clinic’s Center for Regenerative Medicine is sponsoring a roundtable discussion, “Mayo Clinic: Building the Ecosystem in Regenerative Biotherapeutics,” at the International Society for Cell & Gene Therapy’s ISCT 2022 […]
Tags: Center for Regenerative Medicine, Claudia Lucchinetti, International Society for Cell and Gene Therapy, Julie Allickson, Manu Nair, Stephen Ekker, William Faubion Jr.
December 27, 2021
A year of new directions and advancements for regenerative medicine
2021 has been a year of significant innovation across the field of regenerative medicine at Mayo Clinic. Important advancements in preclinical research, as well as new regenerative treatments for patients, further are solidifying Mayo Clinic’s reputation as a world-class leader in regenerative medicine. Regenerative medicine is still a relatively new field of practice, representing a […]
Tags: biomanufacturing, Center for Regenerative Medicine, Janani Reisenauer, Julie Allickson, regenerative medicine, Saad Kenderian
November 19, 2021
Mayo Clinic Symposium on Regenerative Medicine & Surgery recap
“The future of regenerative medicine is bright,” declared Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine, as she delivered the opening keynote address of the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021. Dr. Allickson is the Otto Bremer Trust Director, Biomanufacturing and Product […]
Tags: biomanufacturing, Center for Regenerative Medicine, Julie Allickson, Peter Marks, Richard Gray, Richard Hayden
October 20, 2021
Overcoming regulatory challenges to licensing new biotherapeutics
Mayo Clinic’s Symposium on Regenerative Medicine and Surgery will explore the challenges and opportunities of bringing next-generation biotherapeutics to patients. Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine, will deliver a keynote presentation addressing regulatory hurdles standing between the billions of dollars invested in regenerative […]
Tags: Atta Behfar, biotherapeutics, Center for Regenerative Medicine, Julie Allickson, Mayo Clinic Symposium on Regenerative Medicine & Surgery, Richard Hayden, William Faubion Jr.
September 27, 2021
A robotic GPS for targeting, delivering regenerative biotherapies
A remote-controlled bronchoscope that acts like a GPS system hunts down hard to find lung masses and accurately biopsies them, according to a Mayo Clinic collaborative study. This multisite research, which is published in Annals of Thoracic Surgery, lays the foundation for precisely finding early stage cancer and targeting it with regenerative biotherapeutics needed to […]
Tags: biotherapeutics, Center for Regenerative Medicine, early stage lung cancer, Janani Reisenauer, Julie Allickson, robotic bronchoscope
September 16, 2021
A fountain of youth for aging muscles
Regenerative medicine could hold the keys to rejuvenating older muscles, and research supporting that will be featured at the Mayo Clinic Symposium on Regenerative Medicine and Surgery. Preclinical research by Helen Blau, Ph.D., Stanford University School of Medicine, discovered a protein that triggers muscle loss and a way to block it to restore youthful muscle […]
Tags: aging, Center for Regenerative Medicine, Helen Blau, Julie Allickson, Mayo Clinic Symposium on Regenerative Medicine & Surgery, Richard Hayden, sarcopenia